Stock analysis · Bull Rankings model

THC analysis

Tenet Healthcare CorporationMedical Care Facilities. Scored on the same transparent model behind the daily rankings.

THC
Tenet Healthcare Corporation · Medical Care Facilities
FCF$3.0bB
Rev+5.4%C+
D/E1.52C
P/E10.9xA
PEG1.96C+
49.5Score
$280.77$22.6B
1Y Target$282.48Analyst consensus · 21 analysts
5Y Target$356.62Compound horizon
10Y Target$457.36Long-dated conviction
FCF$3.0bTTM
B
FCF $3.0b — solid, comfortably covers operations and capital return
Rev+5.4%TTM YoY
C+
Revenue +5.4% — steady but below market-beating range
D/E1.52
C
D/E 1.52 — more levered than most Healthcare peers (≈90th pctile)
P/E10.9x
A
P/E 10.9 — cheapest decile in Healthcare (≈10th pctile)
PEG1.96
C+
PEG 1.96 — modest premium; above fair value

Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.

Quality-growth score · 49.5
Quality84.1
Growth34.7
Value41.7
Why this score
  • Buying back stock
  • Durable high returns
Entry · Margin of safety
52-week rangeNear 52-week high
0% off the 12-month high
vs DCF fair value33% belowest. fair value ~$420
What the price assumes: free cash flow compounding at ~-9% a year for the next decade — vs the ~-2% a year our model projects from current growth and analyst estimates.
Quality signals · context only
ROIC40.9% · Areturn on invested capital — not score-weighted

Model-generatedGenerated by the Bull Rankings model from this company's reported fundamentals, and checked against the figures shown above.

Why now
Medical Care Facilities · market cap $22.6b. Trading near 52-week high of $280.89 — momentum setup, limited technical margin of safety. 21 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $282.48 (implying +1% upside).
Moat
Net margin 15% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 68% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. FCF converts 95% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Trading within 0% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction.
Horizon
1-3 yr $282.48 (21-analyst consensus) — multiple re-rating thesis requires a catalyst. 5 yr $356.62 at ~5% CAGR — dividend + buyback compounding. 10 yr $457.36 if the moat survives secular pressure.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

THC vs the Top Picks average

PillarTHCBook avgDiff
Quality0.840.84in line
Growth0.350.84-0.49
Value0.420.78-0.37

Averaged across the 30 names in today's Top Picks (mean score 81.5). A name can beat these averages and still be absent from the book — it also applies concentration limits.

Trend
+6.0 over 47 daily scores
From 43.5 (Jun 22) → 49.5 (now)

One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.

Analyst estimate revisions

30-day change+17.2%
90-day change+17.6%
Forward EPS estimate$20.84

Over the last 90 days, what analysts expect THC to earn is materially higher (+17.6%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.

A rising estimate means expectations are improving, not that the price has failed to keep up — and estimates get cut as readily as they get raised. It is not part of the Bull Rankings score. Biggest movers across the market →

Shares to buy
7
Position size
$1,965
3.9% of portfolio
Stop price
$210.58
25% below $280.77
$ at risk if stopped
$491.35
budget $500.00 · 1% of portfolio

Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.

Tenet Healthcare Corporation (THC): score, valuation & FAQ

Tenet Healthcare Corporation (THC) is a Medical Care Facilities company that scores 49.5 out of 100 on the Bull Rankings quality-growth model — a below-average reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.

Its strongest graded signals are P/E (A). On valuation, THC sits about 33% below our discounted-cash-flow fair value (a margin of safety) — the current price implies roughly -9% annual free-cash-flow growth over the next decade.

Is THC a good stock to buy?

Bull Rankings scores THC 49.5 out of 100 on its quality-growth model, which is a below-average reading. That is driven by P/E (A). A score is a quantitative screen of Tenet Healthcare Corporation's fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

Why does THC score 49.5 on Bull Rankings?

The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). THC earns its highest marks on P/E (A). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.

Is THC overvalued or undervalued?

Based on $280.77, THC sits about 33% below our discounted-cash-flow fair value (a margin of safety) — the current price implies roughly -9% annual free-cash-flow growth over the next decade. It trades at a 10.9x P/E (graded A). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.

What are the main risks of investing in THC?

Trading within 0% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction.

New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.

Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.

More Healthcare Providers stocks by score

All Healthcare rankings →

Analyze another ticker →